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Endothelial cells that functionally express blood brain barrier (BBB) properties are useful surrogates for studying leukocyte-
endothelial cell interactions at the BBB. In this study, we compared two diﬀerent endothelial cellular models: transfected human
brain microvascular endothelial cells (THBMECs) and human umbilical vein endothelial cells (HUVECs). With each grow un-
der optimal conditions, conﬂuent THBMEC cultures showed continuous occludin and ZO-1 immunoreactivity, while HUVEC
cultures exhibited punctate ZO-1 expression at sites of cell-cell contact only. Conﬂuent THBMEC cultures on 24-well collagen-
coated transwell inserts had signiﬁcantly higher transendothelial electrical resistance (TEER) and lower solute permeability than
HUVECs. Conﬂuent THBMECs were more restrictive for mononuclear cell migration than HUVECs. Only THBMECs utilized
abluminal CCL5 to facilitate T-lymphocyte migration in vitro although both THBMECs and HUVECs employed CCL3 to facil-
itate T cell migration. These data establish baseline conditions for using THBMECs to develop in vitro BBB models for studying
leukocyte-endothelial interactions during neuroinﬂammation.
Copyright © 2008 Shumei Man et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Leukocyte recruitment across the blood brain barrier (BBB)
into the perivascular space of the central nervous system
(CNS)isakeystepinthehostdefenseresponsetopathogens,
as well as in neurological disorders such as multiple scle-
rosis (MS), trauma, and stroke [1–3]. Static in vitro BBB
models using brain microvascular endothelial cells (BMECs)
have been used for studying the mechanism of leukocyte-
endothelial interactions at the BBB [4–8]. Basic insights
into leukocyte-endothelial interactions have been obtained
through experiments using human umbilical vein endothe-
lial cells (HUVECs) in both static and dynamic conditions
[9–11].Becauseendothelialcellsfromdiﬀerentvascularbeds
are uniquely adapted to meet the demands of the underly-
ing tissues [12, 13], data from studying HUVECs may not
be directly applicable to leukocyte-endothelial interactions
at the BBB. In this regard, diﬀerences between BMECs and
HUVECs have been reported [14–17]. Transfected human
brain microvascular endothelial cells (THBMECs) were iso-
lated from human brain microvessels and immortalized by
transfection with simian virus 40 large T antigen (SV40-
LT) [14]. THBMECs share characteristics of primary human
brain microvascular endothelial cells (HBMECs) including
expression of tight junction (TJ)-associated proteins and
high transendothelial electrical resistance (TEER) [4, 14].
THBMECs express factor VIII-related antigen and gamma-
glutamyl transpeptidase, and take up 1,1 -dioctadecyl-
3,3,3,3 -tetramethylindocarboxyamine perchlorate-labeled
acetylated low-density lipoprotein [18]. In this paper, we
compare selected features of THBMECs and HUVECs and
focus on their capacity for utilizing abluminal endothelial
cell derived chemokines to facilitate mononuclear cell trans-
migration in vitro.
Chemokines have been proposed to play a major role
in the activation and recruitment of leukocytes to sites of2 Clinical and Developmental Immunology
inﬂammation.CCL5isachemoattractantformultipleleuko-
cyte subtypes (predominantly T cells) via three known
G protein-coupled receptors (GPCRs), CCR1, CCR3, and
CCR5 [19] while CCL3 signals towards a similar spectrum
of mononuclear cells. CCL3 and CCL5 are produced in the
CNS of individuals with several neuroinﬂammatory diseases
including MS. Using conﬂuent THBMEC culture as an in
vitroBBBmodel,anti-CCR1andanti-CCR5antibodiescom-
pletely abrogated CCL5-driven mononuclear cell migration
across a cytokine-activated BBB [5] .T h ed a t ai nt h i sp a p e r
showed that THBMECs diﬀered from HUVECs in their abil-
ity to use abluminal CCL5 to mediate T cellmigration. These
results characterize speciﬁc features that distinguish THB-
MEC from HUVEC cultures, and will help clarify conditions
for the development of models to study leukocyte transmi-
gration across BBB in vitro.
2. METHODS
2.1. Endothelialcellscultureand
leukocytepreparation
THBMECs are adult human brain microvascular endothelial
cellstransfectedandimmortalizedwithaplasmidcontaining
SV40-LT [4–6].THBMECs were grown in RPMI 1640 con-
taining 10% heat-inactivated fetal bovine serum, 10% Nu-
Serum, 2mM L-glutamine, 1mM pyruvate, essential amino
acids, and vitamins. The HUVEC cell lines were purchased
fromAmericanTypeCultureCollectionATCC(ATCCNum-
ber CRL-1730TM) and cultured in Ham’s F12K medium ad-
justed to contain 2 mM L-glutamine, 1.5 g/L sodium bi-
carbonate, 0.1 mg/mL heparin, 0.03 mg/mL endothelial cell
growth supplement (ECGS), and 10% fetal bovine serum.
The THBMECs used in this paper were passages 19–25
and HUVECs were passages 3–7. In order to address their
basic characters, endothelial cells in this paper were not
stimulated with cytokines. Peripheral blood mononuclear
cells (PBMCs) were isolated from fresh whole heparinized
blood of healthy volunteers by density centrifugation us-
ing lymphocyte separation medium (Mediatech Inc., Hern-
don, VA) as previously described [4–6]. PBMCs were resus-
pended at 107 cells/mL in transendothelial migration (TEM)
buﬀer (RPMI 1640 without phenol red +1% bovine serum
albumin) for transmigration assays. For quantiﬁcation of
transmigrated cells, PBMCs were labeled with calcein-AM
(Molecular Probes Inc., Eugene, OR) according to the man-
ufacturer’s instructions and resuspended in the original vol-
ume of TEM buﬀer prior to transmigration assays. The re-
search protocol was approved by the local institutional re-
view board and signed informed consent was obtained from
all donors studied.
2.2. Transendothelialelectricalresistance(TEER)and
solutepermeability
THBMECs and HUVECs were cultured to conﬂuence on
24-well collagen-coated TranswellTM tissue culture inserts
(Corning Costar Inc., Corning, NY). TEER and solute per-
meability were measured as previously described [4–6, 18].
TEER was measured using an EVOM voltohmmeter (World
Precision Instruments Inc., Sarasota, FL). Solute permeabil-
ity was assessed using ﬂuoresceinated dextran-70 (1mg/ml,
Sigma Inc., St. Louis) and ﬂuorescent recovery in the lower
chamber was measured after 15 minutes using a SPECTRA-
max GEMINIXS microplate spectraﬂuorometer (Molecular
Devices Corp., Sunnyvale, CA). Solute permeability was cal-
culatedusingthefollowingformula:(lowerchamberﬂuores-
cence/input ﬂuorescence) × 100%. TEER and solute perme-
ability was determined in triplicate.
2.3. Immunocytochemistry
ZO-1 and occludin were detected by indirect immunocy-
tochemistry on conﬂuent THBMECs and HUVECs as pre-
viously described [20]. Polyclonal rabbit anti-human ZO-1
and anti-human occludin antibodies (1 : 100; Zymed Lab-
oratories Inc., San Francisco, CA) were used in combina-
tion with mouse antirabbit IgG conjugated to FITC (1 : 100;
Southern Biotechnology Associates Inc., Birmingham, AL).
Slides were viewed using a Leica Aristoplan laser scanning
confocal microscope (Leica Wetzlar, Heidelberg , Germany).
2.4. Transmigrationassays
Transmigration assays were performed with Transwell TM
inserts containing conﬂuent THBMEC or HUVEC culture.
Unlabeled and calcein-AM-labeled PBMCs were utilized in
parallel for the quantiﬁcation of PBMC transmigration and
subpopuation analyses as previously described [4–6]. 106
PBMCs from the same donor suspended in TEM buﬀer were
added to the insert and allowed to transmigrate at 37◦C
in a 100% humid atmosphere with 5% CO2 for the indi-
cated time. For chemokine-driven migration, 600μLo fT E M
buﬀer containing 50ng/mL CCL3 or 100ng/mL CCL5 was
placed in the lower chamber (abluminal side of the endothe-
lium). These concentrations had been previously shown to
maximally induce PBMCs migration in transmigration as-
says (data not shown). Migrated cells were collected for sub-
population analysis using ﬂow cytometry. The migration ra-
tio for each leukocyte subpopulation was calculated with the
following formula: [total number of migrated calcein-AM-
labeled PBMCs × subpopulation percentage in migrated
PBMCs]/[total number of input PBMCs × subpopulation
percentage in input PBMCs] × 100%. These assays were per-
formed in quadruplicate, with migration without added ab-
luminal chemokine serving as controls.
2.5. Antibodystainingandﬂowcytometry
Four wells containing migrated PBMCs were pooled for ﬂow
cytometric staining using anti-CD3 PerCP (clone SK7) and
anti-CD14 APC (Leu-3A, all from Becton Dickinson Bio-
sciences, San Jose, CA) as previously described [4–6]D a t a
were collected using an LSR ﬂow cytometer (BD Immunocy-
tometry Systems, San Jose , CA). Analysis was performed us-
ing FlowJo software (Tree Star, Ashland Inc., OR). Mono-
cytes and lymphocytes were gated according to forward andShumei Man et al. 3
side scatter, as well as CD3 and CD14 staining proﬁles and
analyzed against isotype-matched controls.
2.6. Dataanalysis
Statistically signiﬁcant diﬀerences between groups were de-
termined by Student’s t-test, and values of P<. 05 were con-
sidered signiﬁcant.
3. RESULTS
3.1. DifferentpatternsofoccludinandZO-1
immunoreactivityinconﬂuentTHBMECsand
HUVECs
HUVEC have been reported to express TJ proteins when cul-
tured with human astrocyte-conditioned medium [21]. We
addressedTJproteinexpressionbyHUVECsintissueculture
conditionsthatincludedECGSwithbovinepituitaryextract.
Occludin and ZO-1 have regulatory and signaling functions,
acting as cytoskeletal linkers interacting with elements of the
actin cytoskeleton [22]. We assessed ZO-1 and occludin ex-
pression by ﬂuorescent immunocytochemistry using 3 dif-
ferent passages of THBMECs and HUVECs. THBMECs ex-
hibitedstrongandcontinuousZO-1andoccludinexpression
at sites of intercellular contact. In contrast, HUVECs showed
no occludin expression and discontinuous, punctuate ZO-1
staining at the cell-cell interfaces (see Figure 1). We stained
the TJ associated proteins on HUVECs from passages 3–7
and THBMECs of passages 19–25 and obtained consistent
expression patterns.
3.2. ConﬂuentTHBMECcultureshaveahigherTEER
andlowersolutepermeabilitythanHUVEC
TEER and solute permeability are often used to evaluate
the physical properties of endothelial intercellular junctions
[4, 5, 23]. Conﬂuent THBMECs exhibited mean TEER of
100Ω·cm2, values that are consistent with a previous report
for primary brain microvascular endothelial cells [24] while
HUVECs attained an average TEER of 74Ω·cm2 at passage 3
(see Figure 3), which decreased to 33Ω·cm2 at passages 5–7
(data not shown). Conﬂuent THBMECs consistently exhib-
ited a low solute permeability, with average ﬂuorescence re-
covery in bottom wells of 3.4% of input, compared to 6%
for HUVECs at passage 3 (see Figure 2). Solute permeability
of HUVECs increased to 15.9% at passages 5–7. These data
demonstrated that some barrier properties of HUVECs were
passage dependent.
3.3. THBMECsaremorerestrictivetowardsPBMC
transmigrationthanHUVECs
We initially determined the kinetics of PBMCs migration
across THBMEC and HUVEC cultures. The migration of
calcein-AM labeled PBMCs across THBMECs and HUVECs,
as a percentage of input cells, progressively increased over
time (see Figure 3). At passage 3, HUVECs were more per-
missivethanTHBMECsforPBMCsmigrationatboth1hour
and 3 hours (as in Figure 3). The ﬁndings are consistent with
those previously repeated for passages 5–7 HUVEC. We also
ascertained the kinetics of PBMCs subpopulation migration.
Ther ewasap r ogr essi v eincr easeinmo nocyt eandTlymp ho-
cyte migration across both THBMEC and HUVEC cultures,
with higher numbers observed at all time points with conﬂu-
ent HUVECs (Figure 3). This observation demonstrated that
conﬂuent THBMEC cultures were more restrictive towards
the migration of both monocytes and T cells than HUVEC.
3.4.THBMECculturesutilizebothCCL3andCCL5todriveT
cellmigrationwhileHUVECutilizeonlyCCL3
Chemokines are produced primarily by astrocytes, microglia
endothelial cells, and inﬁltrating leukocytes during neuroin-
ﬂammatory disorders such as MS. It remains uncertain how
chemokinesproducedinthebrainparenchymaorwithinen-
dothelialcellscanbesecreted,transported,andimmobilized,
so as to signal to circulating leukocytes. In order to study
question in vitro, a BBB model capable of utilizing those
chemokines highly expressed in neuroinﬂammatory lesions
would be advantageous.
Transmigration assays were performed with CCL3 or
CCL5 introduced in the abluminal side of the TranswellTM
system. CCL5 induced an approximately 5-fold increase in
CD3+TcellmigrationacrossTHBMECsrelativetobasalmi-
gration at 1 hour and 3-fold increase at 3 hours (P<. 05). In
contrast, adding CCL5 to the bottom chamber did not in-
duce a signiﬁcant change in CD3+ T cell migration across
HUVECs (Figure 4). In contrast to CCL5, CCL3 increased
CD3+ T cell migration across both THBMECs and HUVECs
at 3 hours (Figure 4). We also compared CCL5 driven migra-
tion in cultured THBMECs and HUVECs at passage 3 and
found that lower passage HUVECs did not utilize abluminal
CCL5 to facilitate T cell migration (data not shown).
4. DISCUSSION
We compared selected morphological and functional fea-
tures of THBMEC and HUVEC cultures. This analysis in-
cluded junctional protein expression, restriction and selec-
tion in leukocyte recruitment, and utilization of abluminal
CCL3 or CCL5 to drive T cell migration. Our data con-
tinue and extend prior ﬁndings from J.S. Pachtor and his
colleagues (Andjelkovic, IVCDB, 2001). This group devel-
oped a novel model to visualize CCL2-driven monocyte
transendothelial migration into a subendothelial collagen
gel. Compatible with the current report, Pachter et al. found
that BMECs were less permissive than HUVECs for mono-
cyte transendothelial migration. Our study utilized diﬀerent
methods, and also added the new information that T cell mi-
gration is equally aﬀected. Further, we found that CCL5 is
selectively used by THBMECs but not by HUVECs to pro-
mote T cell transmigration. The data showed that morpho-
logical and functional diﬀerences exist between THBMECs
and HUVECs under the deﬁned culture conditions used in
these studies. The ﬁndings were consistent with prior re-
ports [14–17]. It has been reported that BMECs but not HU-
VECs express genes that are important in immunoregulation4 Clinical and Developmental Immunology
HBMEC
Occludin ZO-1
HUVEC
Figure 1: Conﬂuent THBMEC cultures possess intercellular TJs while HUVECs do not. Three diﬀerent passages of THBMECs and HUVECs
were cultured to conﬂuence. Endothelial cells were stained with rabbit anti-human ZO-1 and occludin antibodies followed by FITC conju-
gated goat anti-rabbit IgG. Digital pictures were taken following visualization with a Leica Aristoplan laser scanning confocal microscope.
THBMEC cultures exhibited continuous ZO-1 and occludin expression at sites of intercellular contact. In contrast, HUVEC cultures showed
punctate ZO-1 staining and no occludin immunoreactivity. Scale bar 10μm.
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Figure 2: Conﬂuent THBMEC cultures have a higher TEER and lower solute permeability than HUVEC. THBMECs and HUVECs were
cultured to conﬂuence on 24-well collagen-coated TranswellTM inserts. TEER (a) was measure using an EVOM voltohmmeter. THBMECs
possess higher TEER values. Solute permeability (b) was assessed by adding 100μl of 1mg/mL ﬂuoresceinated dextran-70 in TranswellTM
inserts. Fluorescent recovery in the lower chamber (well) was measured after 15 minutes as stated in Section 2. Triplicate wells were mea-
sured and inserts without cultured endothelial cells were used as controls (data not shown). THBMEC cultures demonstrate a lower solute
permeability. ∗indicates P<. 05 compared with HUVECs.Shumei Man et al. 5
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Figure 3: THBMEC cultures are more restrictive towards PBMCs transmigration than HUVECs. 106 of PBMCs were added into the transwell
inserts containing conﬂuent THBMECs or HUVECs and allowed to transmigrate for the indicated time. Migrated cells were collected and
three color stainings were performed in one step using anti-CD3 PerCP and anti-CD14 APC antibodies. Data were collected with an LSR
ﬂow cytometer and analyzed using FlowJo software. Parallel migration assays were performed using calcein-AM labeled and unlabeled
PBMCs, and migration ratios calculated as stated in Section 2. The assays were performed in quadruplicate using four diﬀerent donors.
Conﬂuent HUVEC cultures are more permissive towards PBMCs migration than THBMECs. ∗indicates P<. 05 comparing THBMECs with
HUVECs. PBMCs transmigration across these endothelial cultures follows the pattern: monocytes > Tc e l l s> B cells (data about B cells not
shown).
(OSM-R beta, decorin, IL-6), growth support (brain-derived
neurotrophic factor, stem cell factor, transforming growth
factor-beta), and angiogenesis (VEGF, erbB1) [25]. In addi-
tion, diﬀerential expression of adhesion molecules between
THBMECs and HUVECs has been described [14]. Our data
focus on functional diﬀerences between THBMEC and HU-
VEC cells with regard to PBMCs transmigration in vitro.
The structural peculiarities of endothelial cells from dif-
ferent tissues or organs are adapted to meet the demands
of the underlying tissue. Intercellular TJs play a key role in
maintaining homeostasis of the brain. The heteropolymers
of occludin and claudin form the intramembrane strands of
TJs while ZO-1 is involved in the formation of cytoplasmic
plaques that connect with occludin [26]. Occludin and ZO-
1 also function as cytoskeletal linkers interacting with actin
cytoskeleton, and are involved in TJ assembly signaling path-
ways [22]. Strong occludin expression is unique to cerebral
endothelial cells and plays a crucial role in the control of vas-
cular permeability, since tissue expression of occludin corre-
l a t e sw e l lw i t hb a r r i e rp r o p e r t i e s[ 27]. Although we did not
address the ultrastructural presence of tight junctions, our
experiments showed that conﬂuent THBMEC cultures ex-
hibited continuous occludin and ZO-1 immunoreactivity at
pointsofintercellularcontactwhileconﬂuentHUVECs(pas-
sages3–7)exhibitedalackofoccludinandpunctateZO-1ex-
pression.IthasbeenreportedthatHUVECsexpressoccludin
and ZO-1 upon culture with astrocyte conditioned medium
[11], and that primary HUVECs expressed occludin at inter-
cellular junctions in BioWhittaker’s endothelial cell growth
medium, which contains bovine brain extract [28]. Given
these disparate ﬁndings, it is likely that passage and culture
conditions greatly aﬀect the intercellular TJ protein expres-
sion in HUVECs while THBMECs consistently express in-
tercellular TJ components. It should be noted that culture
conditions for HUVECs and THBMECs diﬀer, and these dif-
ferences may have contributed to the results we report here.
The interaction between circulating leukocytes and the
endothelium of BBB is a crucial step in diverse pathologic
processes [29, 30]. THBMEC cultures, from passage 19 to
25, in contrast with HUVEC cultures from passage 3 to 7,
were extremely restrictive towards PBMCs transmigration.
Interestingly, although HUVECs at earlier passage showed
higher TEER and lower solute permeability than higher pas-
sages, they supported more PBMCs transmigration than
THBMECs.Currently,therearemainlythreepotentialroutes
knownforleukocytediapedesisacrossendothelialcells:para-
cellular,transcellular,andtricellularcorners[11,31,32].Our
data do not address whether there is increased PBMCs para-
cellular migration across HUVECs.
In our in vitro transmigration assays, monocytes had
much higher migration eﬃciency across both THBMEC and
HUVEC cultures than lymphocytes. About 50 percent of in-
put CD14+ monocytes migrated across conﬂuent THBMEC
cultures after 3 hours, while more than 85 percent of in-
put CD14+ monocytes migrated across HUVEC cultures at
this time point. Although the current studies do not address
this, it is possible that the expression of speciﬁc chemokine
receptors, leukointegrins, and adhesion molecules facilitates
higher rates of monocyte migration in these assays. The
CD14+ monocyte subset comprises nearly 90% of periph-
eral blood monocytes and the vast majority of these cells
express CCR1, CCR2, CXCR2, CXCR4, and α4β1 integrins
[14, 33–36]. Our previous work showed that most input
CD14+ monocytes express CCR2 and THBMECs produce
CCL2 under resting conditions [4–6]. We also demonstrated
that conﬂuent THBMECs express ﬁbronectin connecting
segment-1 (FN CS-1), a high aﬃnity receptor for α4β1 inte-
grin, and showed that chemokine-driven CD14+ monocyte6 Clinical and Developmental Immunology
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Figure 4: THBMEC cultures utilize both CCL3 and CCL5 to drive T
cell migration while HUVEC cultures utilize CCL3 only. THBMECs
or HUVECs were cultured to conﬂuence on Transwell TM inserts.
106 of PBMCs from the same donor were added into the inserts
with or without 50ng/mL CCL3 or 100ng/mL CCL5 added to the
lower chamber (well). Migration ratios were calculated as described
in Section 2. CCL3 facilitated T cell migration across both THB-
MECs and HUVECs while CCL5 induced T cell migration across
THBMECs only. The assays were performed in quadruplicate for
eachdonorandthreedonorswereincluded. ∗indicatesP <.05com-
pared to basal migration without added chemokine.
transmigration was dependent on α4β1/FN CS-1 interac-
tions [5]. These observations suggest that CCR2+ CD14+
monocytes interact with endogenous CCL2 produced by
THBMECs, with resultant chemokine-induced α4β1 integrin
activation, followed by transmigration through α4β1 inte-
grin/FN CS-1 interactions. Analogous mechanisms may ex-
plain the high rates of CD14+ monocyte migration across
HUVECs.
Tcellsmigratedatmuchlowerrates,comparedtomono-
cytes in these assays, across both THBMECs and HUVECs.
It is worth noting that activated lymphocytes, which mi-
grate eﬃciently in these assays, are present at relatively low
abundance (10–20% of PBMCs) in the circulation. The low
rates of T cell migration could also be explained partially by
the observation that HUVECs and THBMECs exhibit low
constitutive expression of ICAM-1, an important determi-
nant for T cell adhesion and transmigration [5, 37, 38]. The
speciﬁc expression of chemokines and adhesion molecules
doubtless plays key roles in the selective recruitment of
leukocytes across the BBB [33, 34].
Finally,inthisstudy,weaddressedthecapabilityofTHB-
MECs and HUVECs to utilize chemokines CCL3 and CCL5
to enhance PBMCs transmigration in vitro.U n e x p e c t e d l y ,
the data showed that conﬂuent THBMECs could utilize both
CCL3andCCL5tofacilitateTcellmigration,whileHUVECs
only employed CCL3 to drive T cell migration in vitro.O u r
data do not address the mechanisms underlying these diﬀer-
ences. Characterizing the properties of peripherally-derived
and CNS-derived endothelial cells in vitro will aid interpre-
tation of data from model systems in the context of inﬂam-
matory CNS disease.
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